Subcutaneous cardioverter defibrillator has longer time to therapy but is less cardiotoxic than transvenous cardioverter defibrillator. Study carried out in a preclinical porcine model
Journal article published in 2017 by
Rodrigue Garcia,
Sofiane Inal,
Frederic Favreau,
Christophe Jayle,
Thierry Hauet 
,
Patrick Bruneval,
Thomas Kerforne,
Jamil Hajj-Chahine,
Bruno Degand
,
Patrick Bruneval,
Thomas Kerforne,
Jamil Hajj-Chahine,
Bruno Degand
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 